Research Article

Clinical Factors and Outcomes When Real-World Heart Teams Overruled STS Risk Scores in TAVR Cases

Table 4

Outcomes by study groups.

TAVRTAVRSAVR value (TAVR, STS PROM > 3% vs. ≤3%) value (STS PROM ≤ 3%, TAVR vs. SAVR)
STS PROM ≤ 3% (N = 415)STS PROM > 3% (N = 2,711)STS PROM ≤ 3% (N = 1,438)

Postprocedural
 Transfusion, N (%)21 (5.1%)292 (10.8%)205 (14.3%)<0.001<0.001
 Units of RBC transfused, mean ± SD0.2 ± 1.00.3 ± 1.20.4 ± 1.40.029<0.001
 Postoperation length of stay (days), mean ± SD2.5 ± 3.43.5 ± 4.75.9 ± 3.6<0.001<0.001
 Postoperation length of stay (days), median (IQR)2.0 (1.0–3.0)2.0 (1.0–4.0)5.0 (4.0–6.0)<0.001<0.001
 Discharge to home, N (%)385 (93.9%)2235 (84.6%)1248 (86.8%)<0.001<0.001
 Death in hospital, N (%)5 (1.2%)70 (2.6%)4 (0.3%)0.0880.031
 Significant cardiac event, N (%)5 (1.2%)46 (1.7%)0.461
 Stroke, N (%)5 (1.2%)57 (2.1%)11 (0.8%)0.2220.394
 Acute kidney injury (stage 3), N (%)3 (0.7%)52 (2.1%)13 (0.9%)0.076>0.999
 Bleeding (disabling or life threatening), N (%)6 (1.4%)79 (2.9%)0.086
 Vascular access site complications, N (%)17 (4.1%)160 (5.9%)0.138
 Device complications, N (%)4 (1.0%)26 (1.0%)>0.999
 Aortic regurgitation (moderate to severe), N (%)6 (1.5%)52 (2.1%)1 (0.7%)0.4630.684
 Requirement for pacer or ICD, N (%)26 (6.9%)216 (9.5%)58 (4.2%)0.0990.027

30-day follow-up
 Mortality within 30-day, N (%)8 (2.0%)95 (3.6%)9 (0.6%)0.0970.012
 Readmission within 30 days, N (%)36 (8.9%)269 (10.3%)107 (7.5%)0.3920.349

1-year follow-up
 1year survival status, N (%)
  Alive342 (82.4%)2138 (78.9%)0.005
  Died34 (8.2%)371 (13.7%)
  Unknown39 (9.4%)202 (7.5%)
  Survival at 1 year, % (95% CI)91.6 (88.5–93.9)86.0 (84.6–87.2)0.002
  Readmission free at 1 year, % (95% CI)^71.5 (66.8–76.0)71.1 (69.3–72.9)0.721

Blank responses in the SAVR group represent data not collected in STS Adult Cardiac Surgery Database. Abbreviations: SD=standard deviation; STS PROM=predicted risk of mortality for surgical aortic valve replacement based on the Society for Thoracic Surgeon's risk model; ICD=implantable cardioverter defibrillator. Kaplan–Meier estimation; ^cumulative incidence function.